Consequences of novel Coronavirus infection on brain health are significant, requiring frequent brain monitoring Brain diagnostics in infected patients extremely limited due to their severe physical illnesses; traditional EEG time consuming, exposes frontline workers to…
Seizures have been common in hospitalized COVID-19 patients, and the death rate higher in those who experienced the seizures Due to a shortage of PPE and limited contact, EEG accessibility was limited during the pandemic…
Brain Scientific (OTCQB: BRSF), a commercial-stage medical device and software company focused on neurology, was recently featured in Neoscope (a publication by Futurism) as a company that champions cutting-edge research that is shaping the future…
BRSF featured in industry publication as a company that transforms EEG testing in children, cutting procedure time from 30 to as little as 5 minutes. The need for brain diagnostics in children is on the…
Brain Scientific (OTCQB: BRSF), focused on modernizing the brain diagnostic market through cutting-edge technologies, recently began a collaboration with JelikaLite in a clinical trial. The clinical trial, which has 30 participants from two New York…
BRSF made strides on operations front to improve lead times, quality control Company experienced revenue growth, increase in assets and R&D Brain Scientific has identified that only 30% of U.S. hospitals have equipment for routine EEGs…
First order marks a significant milestone as Veterans Affairs runs the largest integrated healthcare system in the country BRSF hopes the relationship will bring cutting-edge brain diagnostics to a nationwide network of veterans’ health care Brain Scientific (OTCQB: BRSF), a commercial-stage, neurology-focused medical device and software company, has…
Brain Scientific (OTCQB: BRSF), focused on modernizing the brain diagnostic market through cutting-edge technologies, has sought to narrow the wide access-to-neurological-care gap through portable EEGs, teleneurology, on-demand data exchange and AI predictive biomarkers. “By creating…
Brain Scientific was featured in Neoscope, a publication of Futurism, a media company concentrating on the scientific and technological advances for the future Article details e-tattoo, BRSF’s solution that can capture big data in real-time…
Commercial application of NeuroEEG and NeuroCap growing across ICUs, acute inpatient care and other emergency care in U.S. BRSF plans to launch devices in Canada Company expands footprint, plans patent applications in Latin America, Europe…
Brain Scientific (OTCQB: BRSF), focused on modernizing the brain diagnostic market through cutting-edge technologies, has created two FDA-cleared products (the NeuroCap(TM) and NeuroEEG(TM)) that are nothing like other brain-computer interface (“BCI”) solutions in the market.…
BRSF announced it has FDA clearance for next-gen NeuroCap The newest version of the NeuroCap has added velcro strips, expanded size range to include pediatrics New device can stay on the patient’s head for up…
BRSF and JelikaLite have joined forces in a clinical trial for reducing autism symptoms in children JelikaLite uses PRM therapy to reduce autism symptoms BRSF sees this as an important step forward in wider adoption…
Brain Scientific (OTCQB: BRSF),a neurology-focused medical device and software company, has released its 2020 financial results and has filed its annual report for the fiscal year ended Dec. 31, 2020. Company highlights include bringing the…
Brain Scientific (OTCQB: BRSF), focused on modernizing the brain diagnostic market through cutting-edge technologies, is fulfilling a growing need for improved neurological monitoring that is cost efficient, disposable and portable. When combating a highly contagious…
Distribution of neurologists across the U.S. is uneven with 20 states experiencing neurology deserts Brain Scientific has developed tools that help providers in neurology deserts provide access to neurological care With explosion of telemedicine services…
BRSF is creating mobile, easy-to-use electroencephalogram (“EEG”) devices that enhance research integrity There is an increasing desire to understand the brain’s capabilities and harness them for healing Brain Scientific provides a cost-efficient, pre-gelled, disposable and…
Researchers struggle to understand the immediate effects of COVID, with no clear census on the long-term neurological impact COVID-19 has shown itself to be unique in how it interacts with the brain Brain e-tattoos implanted…
Brain Scientific (OTCQB: BRSF), with its low-cost, portable, wireless and easy-to-use electroencephalogram (“EEG”) devices, the NeuroCap(TM) and NeuroEEG(TM), has overcome the barriers preventing the use of EEGs in emergency settings. This means that patients and…
Brain Scientific (OTCQB: BRSF), a neurology focused medical device and software company, recently announced a collaboration with JelikaLite, a company developing Cognilum(TM), a non-invasive wearable photobiomodulation device that is being developed to increase the well-being…